Journal article

Galantamine vs donepezil in the treatment of Alzheimer's disease.

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Goldlist, B., Gordon, M., & Naglie, G. (2003). Galantamine vs donepezil in the treatment of Alzheimer's disease. Drugs and Aging, 20(15), 1139–1140.

MLA Style

Goldlist, B., et al. “Galantamine vs Donepezil in the Treatment of Alzheimer's Disease.” Drugs and Aging, vol. 20, no. 15, 2003, pp. 1139–40.

Chicago Style

Goldlist, B, M Gordon, and G Naglie. 2003. “Galantamine vs Donepezil in the Treatment of Alzheimer's Disease.” Drugs and Aging 20 (15): 1139–40.
Share
Print

Access Document

Publisher copy:: 10.2165/00002512-200320150-00009

Authors

+ Goldlist, B More by this author

Role:: Author

+ Gordon, M More by this author

Role:: Author

+ Naglie, G More by this author

Role:: Author

Journal:: Drugs and aging More from this journal
Volume:: 20
Issue:: 15
Pages:: 1139-1140
Publication date:: 2003-01-01
DOI:: 10.2165/00002512-200320150-00009
ISSN:: 1170-229X

Language:: English
Keywords:: Piperidines

Alzheimer Disease

Galantamine

Cholinesterase Inhibitors

Indans

Clinical Trials as Topic

Humans
Pubs id:: pubs:80117
UUID:: uuid:d3414f54-bd7c-4620-a13f-340a89fb5d6a
Local pid:: pubs:80117
Source identifiers:: 80117
Deposit date:: 2012-12-19

Terms of use

Copyright date:: 2003

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP